Clene (NASDAQ: CLNN) to Present at Emerging Growth Conference on June 12, 2024
Clene (NASDAQ: CLNN) and its subsidiary Clene Nanomedicine Inc. will discuss their focus on improving mitochondrial health to treat neurodegenerative diseases at the Emerging Growth Conference on June 12, 2024.
This news matters as it provides insight into Clene's efforts to develop a first-in-class therapy for neurodegenerative diseases, potentially impacting the lives of those suffering from conditions like ALS, Parkinson's, and MS.
